The reductase steps of the type II fatty acid synthase as antimicrobial targets

Lipids

Volumn 39, Issue 11, 2004, Pages 1055-1060

  Zhang, Yong Mei ^a   Lu, Ying Jie ^a   Rock, Charles O ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; BIOCHEMISTRY; BIOSYNTHESIS; CRYSTAL STRUCTURE; GENES; PATHOLOGY;

ANTIBACTERIAL AGENTS; GRAM-POSITIVE PATHOGENS; MULTIDRUG RESISTANCE; NOVEL ANTIBIOTICS;

PROTEINS;

AMINOPYRIDINE DERIVATIVE; ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA KETOACYL CARRIER PROTEIN REDUCTASE; ENOYL ACYL CARRIER PROTEIN REDUCTASE; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE 2; FATTY ACID SYNTHASE INHIBITOR; GENZ 10850; GENZ 8575; IMIDAZOLE DERIVATIVE; ISONIAZID; OXIDOREDUCTASE; THIOLACTOMYCIN; TRICLOSAN; UNCLASSIFIED DRUG;

CATALYSIS; CONFERENCE PAPER; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG SYNTHESIS; DRUG TARGETING; ENZYME REGULATION; ENZYME STRUCTURE; ESCHERICHIA COLI; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MAMMAL; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; STRUCTURE ANALYSIS;

ANTI-BACTERIAL AGENTS; CATALYSIS; ENZYME INHIBITORS; FATTY ACID SYNTHETASE COMPLEX; HUMANS; OXIDOREDUCTASES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; NEGIBACTERIA; POSIBACTERIA;

EID: 12344300344     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-004-1330-3     Document Type: Conference Paper

References (47)

1. Cronan, J.E., Jr., and Rock, C.O. (1996) Biosynthesis of Membrane Lipids, in Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology (Neidhardt, F.C., Curtis, R., Gross, C.A., Ingraham, J.L., Lin, E.C.C., Low, K.B., Magasanik, B., Reznikoff, W., Riley, M., Schaechter, M., and Umbarger, H.E., eds.), pp. 612-636, American Society for Microbiology, Washington, D.C.
2. Rock, C.O., and Cronan, J.E., Jr. (1996) Escherichia coli as a Model for the Regulation of Dissociable (Type II) FA Biosynthesis, Biochim. Biophys. Acta 1302, 1-16.
3. Rock, C.O., and Jackowski, S. (2002) Forty Years of FA Biosynthesis, Biochem. Biophys. Res. Commun. 292, 1155-1166.
4. Heath, R.J., and Rock, C.O. (2004) FA Biosynthesis as a Target for Novel Antibacterials, Curr. Opin. Investig. Drugs 5, 146-153.
5. Heath, R.J., White, S.W., and Rock, C.O. (2001) Lipid Biosynthesis as a Target for Antibacterial Agents, Prog. Lipid Res. 40, 467-497.
6. Campbell, J.W., and Cronan, J.E., Jr. (2001) Bacterial FA Biosynthesis: Targets for Antibacterial Drug Discovery, Annu. Rev. Microbiol. 55, 305-332.
7. McMurray, L.M., Oethinger, M., and Levy, S. (1998) Triclosan Targets Lipid Synthesis, Nature (London) 394, 531-532.
8. Heath, R.J., Yu, Y.-T., Shapiro, M.A., Olson, E., and Rock, C.O. (1998) Broad Spectrum Antimicrobial Biocides Target the FabI Component of FA Synthesis, J. Biol. Chem. 273, 30316-30321.
9. Banerjee, A., Dubnau, E., Quémard, A., Balasubramanian, V., Um, K.S., Wilson, T., Collins, D., de Lisle, G., and Jacobs, W.R., Jr. (1994) inhA, a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis, Science 263, 227-230.
10. Hayashi, T., Yamamoto, O., Sasaki, H., and Okazaki, H. (1984) Inhibition of FA Synthesis by the Antibiotic Thiolactomycin, J. Antibiot. (Tokyo) 37, 1456-1461.
11. Foth, B.J., Ralph, S.A., Tonkin, C.J., Struck, N.S., Fraunholz, M., Roos, D.S., Cowman, A.F., and McFadden, G.I. (2003) Dissecting Apicoplast Targeting in the Malaria Parasite Plasmodium falciparum, Science 299, 705-708.
12. Waller, R.F., Ralph, S.A., Reed, M.B., Su, V., Douglas, J.D., Minnikin, D.E., Cowman, A.F., Besra, G.S., and McFadden, G.I. (2003) A Type II Pathway for FA Biosynthesis Presents Drug Targets in Plasmodium falciparum, Antimicrob. Agents Chemother. 47, 297-301.
13. Surolia, N., and Surolia, A. (2001) Triclosan Offers Protection Against Blood Stages of Malaria by Inhibiting Enoyl-ACP Reductase of Plasmodium falciparum, Nat. Med. 7, 167-173.
14. Heath, R.J., Rubin, J.R., Holland, D.R., Zhang, E., Snow, M.E., and Rock, C.O. (1999) Mechanism of Triclosan Inhibition of Bacterial FA Synthesis, J. Biol. Chem. 274, 11110-11114.
15. Heath, R.J., and Rock, C.O. (1995) Enoyl-acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of FA Elongation in Escherichia coli, J. Biol. Chem. 270, 26538-26542.
16. Turnowsky, F., Fuchs, K., Jeschek, C., and Högenauer, G. (1989) envM Genes of Salmonella typhimurium and Escherichia coli, J. Bacteriol. 171, 6555-6565.
17. Heath, R.J., Li, J., Roland, G.E., and Rock, C.O. (2000) Inhibition of the Staphylococcus aureus NADPH-Dependent Enoyl-acyl Carrier Protein Reductase by Triclosan and Hexachlorophene, J. Biol. Chem. 275, 4654-4659.
18. Heath, R.J., and Rock, C.O. (2000) A Triclosan-Resistant Bacterial Enzyme, Nature (London) 406, 145-146.
19. Marrakchi, H., DeWolf, W.E., Jr., Quinn, C., West, J., Polizzi, B.J., So, C.Y., Holmes, D.J., Reed, S.L., Heath, R.J., Payne, D.J., et al. (2003) Characterization of Streptococcus pneumoniae Enoyl-[Acyl Carrier Protein] Reductase (FabK), Biochem. J. 370, 1055-1062.
20. Heath, R.J., Su, N., Murphy, C.K., and Rock, C.O. (2000) The Enoyl-[Acyl-Carrier-Protein] Reductases FabI and FabL from Bacillus subtilis, J. Biol. Chem. 275, 40128-40133.
21. Dessen, A., Quémard, A., Blanchard, J.S., Jacobs, W.R., Jr., and Sacchettini, J.C. (1995) Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis, Science 267, 1638-1641.
22. Kuo, M.R., Morbidoni, H.R., Alland, D., Sneddon, S.F., Gourlie, B.B., Staveski, M.M., Leonard, M., Gregory, J.S., Janjigian, A.D., Yee, C., et al. (2003) Targeting Tuberculosis and Malaria Through Inhibition of Enoyl Reductase: Compound Activity and Structural Data, J. Biol. Chem. 278, 20851-20859.
23. Stewart, M.J., Parikh, S., Xiao, G., Tonge, P.J., and Kisker, C. (1999) Structural Basis and Mechanism of Enoyl Reductase Inhibition by Triclosan, J. Mol. Biol. 290, 859-865.
24. Fan, F., Yan, K., Wallis, N.G., Reed, S., Moore, T.D., Rittenhouse, S.F., DeWolf, J.W., Jr., Huang, J., McDevitt, D., Miller, W.H., et al. (2002) Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates of Staphylococcus aureus, Antimicrob. Agents Chemother. 46, 3343-3347.
25. Sivaraman, S., Zwahlen, J., Bell, A.F., Hedstrom, L., and Tonge, P.J. (2003) Structure-Activity Studies of the Inhibition of FabI, the Enoyl Reductase from Escherichia coli, by Triclosan: Kinetic Analysis of Mutant FabIs, Biochemistry 42, 4406-4413.
26. Rawat, R., Whitty, A., and Tonge, P.J. (2003) The Isoniazid-NAD Adduct Is a Slow, Tight-Binding Inhibitor of InhA, the Mycobacterium tuberculosis Enoyl Reductase: Adduct Affinity and Drug Resistance, Proc. Natl. Acad. Sci. USA 100, 13881-13886.
27. McMurry, L.M., McDermott, P.F., and Levy, S.B. (1999) Genetic Evidence that InhA of Mycobacterium smegmatis Is a Target for Triclosan, Antimicrob. Agents Chemother. 43, 711-713.
28. Perozzo, R., Kuo, M., Sidhu, A.S., Valiyaveettil, J.T., Bittman, R., Jacobs, W.R., Jr., Fidock, D.A., and Sacchettini, J.C. (2002) Structural Elucidation of the Specificity of the Antibacterial Agent Triclosan for Malarial Enoyl Acyl Carrier Protein Reductase, J. Biol. Chem. 277, 13106-13114.
29. Kapoor, M., Dar, M.J., Surolia, A., and Surolia, N. (2001) Kinetic Determinants of the Interaction of Enoyl-ACP Reductase from Plasmodium falciparum with Its Substrates and Inhibitors, Biochem. Biophys. Res. Commun. 289, 832-837.
30. Sivaraman, S., Sullivan, T.J., Johnson, F., Novichenok, P., Cui, G., Simmerling, C., and Tonge, P.J. (2004) Inhibition of the Bacterial Enoyl Reductase FabI by Triclosan: A Structure-Reactivity Analysis of FabI Inhibition by Triclosan Analogues, J. Med. Chem. 47, 509-518.
31. Heerding, D.A., Chan, G., DeWolf, W.E., Fosberry, A.P., Janson, C.A., Jaworski, D.D., McManus, E., Miller, W.H., Moore, T.D., Payne, D.J., et al. (2001) 1,4-Disubstituted Imidazoles Are Potential Antibacterial Agents Functioning as Inhibitors of Enoyl Acyl Carrier Protein Reductase (FabI), Bioorg. Med. Chem. Lett. 11, 2061-2065.
32. Seefeld, M.A., Miller, W.H., Newlander, K.A., Burgess, W.J., Payne, D.J., Rittenhouse, S.F., Moore, T.D., DeWolf, W.E., Jr., Keller, P.M., Qiu, X., et al. (2001) Inhibitors of Bacterial Enoyl Acyl Carrier Protein Reductase (FabI): 2,9-Disubstituted 1,2,3,4-Tetrahydropyrido[3,4-b]indoles as Potential Antibacterial Agents, Bioorg. Med. Chem. Lett. 11, 2241-2244.
33. Payne, D.J., Miller, W.H., Berry, V., Brosky, J., Burgess, W.J., Chen, E., DeWolf, J.W., Jr., Fosberry, A.P., Greenwood, R., Head, M.S., et al. (2002) Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents, Antimicrob. Agents Chemother. 46, 3118-3124.
34. Miller, W.H., Seefeld, M.A., Newlander, K.A., Uzinskas, I.N., Burgess, W.J., Heerding, D.A., Yuan, C.C., Head, M.S., Payne, D.J., Rittenhouse, S.F., et al. (2002) Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI), J. Med. Chem. 45, 3246-3256.
35. Seefeld, M.A., Miller, W.H., Newlander, K.A., Burgess, W.J., DeWolf, W.E., Jr., Elkins, P.A., Head, M.S., Jakas, D.R., Janson, C.A., Keller, P.M., et al. (2003) Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK, J. Med. Chem. 46, 1627-1635.
36. Sheldon, P.S., Kekwick, R.G., Smith, C.G., Sidebottom, C., and Slabas, A.R. (1992) 3-Oxoacyl-[ACP] Reductase from Oilseed Rape (Brassica napus), Biochim. Biophys. Acta 1120, 151-159.
37. Fawcett, T., Copse, C.L., Simon, J.W., and Slabas, A.R. (2000) Kinetic Mechanism of NADH-Enoyl-ACP Reductase from Brassica napus, FEBS Lett. 484, 65-68.
38. Price, A.C., Zhang, Y.-M., Rock, C.O., and White, S.W. (2001) The Structure of β-Ketoacyl-[Acyl Carrier Protein] Reductase from Escherichia coli: Negative Cooperativity and Its Structural Basis, Biochemistry 40, 12772-12781.
39. Price, A.C., Zhang, Y.-M., Rock, C.O., and White, S.W. (2004) Cofactor-Induced Conformational Rearrangements Establish a Catalytically Competent Active Site and a Proton Relay Conduit in β-Ketoacyl-Acyl Carrier Protein Reductase (FabG), Structure 12, 417-428.
40. Cohen-Gonsaud, M., Ducasse, S., Hoh, F., Zerbib, D., Labesse, G., and Quemard, A. (2002) Crystal Structure of MabA from Mycobacterium tuberculosis, a Reductase Involved in Long-Chain FA Biosynthesis, J. Mol. Biol. 320, 249-261.
41. Zhang, Y., and Cronan, J.E., Jr. (1996) Polar Allele Duplication for Transcriptional Analysis of Consecutive Essential Genes: Application to a Cluster of Escherichia coli FA Biosynthetic Genes, J. Bacteriol. 178, 3614-3620.
42. Lai, C.Y., and Cronan, J.E., Jr. (2004) Isolation and Characterization of β-Ketoacyl-Acyl Carrier Protein Reductase (fabG) Mutants of Escherichia coli and Salmonella enterica Serovar Typhimurium, J. Bacteriol. 186, 1869-1878.
43. Zhang, Y.-M., and Rock, C.O. (2004) Evaluation of Epigallocatechin Gallate and Related Plant Polyphenols as Inhibitors of the FabG and FabI Reductases of Bacterial Type II FA Synthase, J. Biol. Chem. 279, 30994-31001.
44. Ducasse-Cabanot, S., Cohen-Gonsaud, M., Marrakchi, H., Nguyen, M., Zerbib, D., Bernadou, J., Daffe, M., Labesse, G., and Quemard, A. (2004) In vitro Inhibition of the Mycobacterium tuberculosis β-Ketoacyl-Acyl Carrier Protein Reductase MabA by Isoniazid, Antimicrobial. Agents Chem. 48, 242-249.
45. Lei, B., Wei, C.J., and Tu, S.C. (2000) Action Mechanism of Antitubercular Isoniazid. Activation by Mycobacterium tuberculosis KatG, Isolation, and Characterization of InhA Inhibitor, J. Biol. Chem. 275, 2520-2526.
46. Rozwarski, D., Grant, G., Barton, D., Jacobs, W., and Sacchettini, J.C. (1998) Modification of NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis, Science 279, 98-102.
47. Banerjee, A., Sugantino, M., Sacchettini, J.C., and Jacobs, W.R., Jr. (1998) The mabA Gene from the inhA Operon of Mycobacterium tuberculosis Encodes a 3-Ketoacyl Reductase That Fails to Confer Isoniazid Resistance, Microbiology 144, 2697-2704.